Litcius/Paper detail

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition

Richard Riedel, Jana Fassunke, Andreas H. Scheel, Matthias Scheffler, Carina Heydt, Lucia Nogová, Sebastian Michels, R. Fischer, Anna Eisert, Heather Scharpenseel, Felix John, Lea Ruge, Diana Schaufler, Janna Siemanowski, Michaela A. Ihle, Svenja Wagener‐Ryczek, Roberto Pappesch, Jan Rehker, Anne Bunck, Carsten Kobe, Felix Keil, Sabine Merkelbach‐Bruse, Reinhard Büttner, Jürgen Wolf

2023Journal of Thoracic Oncology19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCohortOncologyFusion geneInternal medicineAdenocarcinomaConfidence intervalDiseaseDemographicsMutationCancerGeneGeneticsDemographySociologyBiologyLung Cancer Treatments and MutationsLiver physiology and pathologyMelanoma and MAPK Pathways
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition | Litcius